KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $181.0 million.

  • Bausch Health Companies' Net Income towards Common Stockholders rose 29673.91% to $181.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.0 million, marking a year-over-year increase of 24792.63%. This contributed to the annual value of -$72.0 million for FY2024, which is 8821.6% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Net Income towards Common Stockholders is $181.0 million, which was up 29673.91% from $128.0 million recorded in Q2 2025.
  • Bausch Health Companies' Net Income towards Common Stockholders' 5-year high stood at $403.0 million during Q3 2022, with a 5-year trough of -$680.0 million in Q1 2021.
  • In the last 5 years, Bausch Health Companies' Net Income towards Common Stockholders had a median value of -$66.0 million in 2022 and averaged -$92.5 million.
  • In the last 5 years, Bausch Health Companies' Net Income towards Common Stockholders crashed by 66944.44% in 2022 and then surged by 1290000.0% in 2025.
  • Bausch Health Companies' Net Income towards Common Stockholders (Quarter) stood at $72.0 million in 2021, then crashed by 669.44% to -$410.0 million in 2022, then surged by 88.54% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then soared by 84.69% to $181.0 million in 2025.
  • Its last three reported values are $181.0 million in Q3 2025, $128.0 million for Q2 2025, and -$86.0 million during Q1 2025.